Guided Therapeutics Income Statement (2010-2025) | GTHP

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Revenue & Cost
Revenue (Quarter)		0.00M	0.02M	0.06M	0.01M	0.01M	0.00M		0.02M	0.04M		0.03M	0.01M			0.00M		0.12M	0.06M	0.59M
Interest income
Interest Income - Total (Quarter)												0.01M	0.00M
Interest expenses
Interest Expense - Debt (Quarter)		0.01M			0.04M	-0.01M
Interest Expenses (Quarter)	0.14M	0.32M	0.59M	0.10M	0.10M	0.26M	0.15M	0.07M	0.07M	0.07M	0.07M	0.07M	0.06M	0.07M	0.11M	0.13M	0.15M	0.16M	0.13M	0.18M
Interest Income - Net (Quarter)									-0.07M	-0.07M	-0.07M	-0.07M	-0.06M	-0.07M	-0.11M	-0.13M	-0.15M	-0.16M
Operating Items
Research & Development (Quarter)	0.02M	0.02M	0.02M	0.02M	0.02M	0.01M	0.01M	0.04M	0.01M	0.07M	0.07M	0.09M	0.05M	0.22M	0.11M	0.14M	0.07M	0.13M	0.14M	0.13M
Selling, General & Administrative (Quarter)	0.77M	0.51M	0.41M	0.42M	0.39M	0.68M	1.17M	0.78M	0.78M	1.39M	0.48M	0.35M	0.24M	0.36M	0.37M	0.32M	0.27M	0.66M	0.36M	1.02M
Other Operating Expenses (Quarter)	0.04M	0.03M	0.04M	0.03M	0.04M	-0.00M	0.05M	0.05M	0.07M	0.06M	0.07M	0.07M	0.07M	0.07M	0.08M	0.07M	0.07M	0.05M	0.02M	0.02M
Operating Expenses (Quarter)	0.82M	0.56M	0.46M	0.48M	0.45M	0.72M	1.23M	0.87M	0.86M	1.52M	0.62M	0.50M	0.36M	0.66M	0.56M	0.53M	0.41M	0.84M	0.52M	1.17M
Operating Income (Quarter)	-0.82M	-0.56M	-0.49M	-0.43M	-0.44M	-0.72M	-1.22M	-0.95M	-0.84M	-1.50M	-0.62M	-0.48M	-0.36M	-0.66M	-0.56M	-0.53M	-0.41M	-0.76M	-0.48M	-0.71M
EBIT (Quarter)	-0.82M	-0.56M	-0.49M	-0.43M	-0.44M	-0.72M	-1.22M	-0.95M	-0.84M	-1.50M	-0.62M	-0.48M	-0.36M	-0.66M	-0.56M	-0.53M	-0.41M	-0.76M	-0.48M	-0.71M
Non-operating items
Other Non Operating Income (Quarter)	-0.09M	-0.47M	0.76M	0.54M	-0.06M	0.00M	0.00M	0.01M		0.02M	0.02M	-0.03M	0.00M	-0.01M		-0.01M	0.10M		-0.04M	-0.58M
Non Operating Income (Quarter)		-0.47M	0.56M	-0.01M	-0.06M	-0.21M	0.00M	0.01M		-0.05M	-0.05M	0.17M	0.00M	0.01M	-0.09M	-0.12M	0.10M	-0.05M	-0.26M	-0.51M
Net income details
EBT (Quarter)	-0.52M	-1.03M	0.07M	-0.44M	-0.51M	-0.93M	-1.10M	-1.81M	-0.87M	-1.56M	-0.68M	-0.39M	-0.40M	-0.71M	-0.65M	-0.65M	-0.43M	-0.81M	-0.74M	-1.22M
Profit After Tax (Quarter)	-0.52M	-1.03M	0.07M	-0.44M	-0.51M	-0.93M	-1.10M	-1.81M	-0.87M	-1.56M	-0.68M	-0.39M	-402.00	-0.71M	-0.65M	-0.65M	-427.00	-0.81M	-0.74M	-1.22M
Income from Continuing Operations (Quarter)	-0.52M	-1.03M	0.07M	-0.44M	-0.51M	-0.93M	-1.10M	-1.81M	-0.87M	-1.56M	-0.68M	-0.39M	-0.40M	-0.71M	-0.65M	-0.65M	-0.43M	-0.81M	-0.74M	-1.22M
Consolidated Net Income (Quarter)	-0.52M	-1.03M	0.07M	-0.44M	-0.51M	-0.93M	-1.10M	-1.81M	-0.87M	-1.56M	-0.68M	-0.39M	-0.40M	-0.71M	-0.65M	-0.65M	-0.43M	-0.81M	-0.74M	-1.22M
Income towards Parent Company (Quarter)	-0.52M	-1.03M	0.07M	-0.44M	-0.51M	-0.93M	-1.10M	-1.81M	-0.87M	-1.56M	-0.68M	-0.39M	-0.40M	-0.71M	-0.65M	-0.65M	-0.43M	-0.81M	-0.74M	-1.22M
Preferred Dividend Payments (Quarter)	-0.06M	0.12M	0.12M	0.07M	0.55M	0.08M	0.05M	0.05M	0.04M	0.05M	0.04M	0.05M	0.04M	0.05M	0.04M	0.05M	0.04M	0.04M	0.04M	0.02M
Net Income towards Common Stockholders (Quarter)	-0.57M	-1.16M	-0.05M	-0.51M	-1.05M	-1.01M	-1.05M	-1.86M	-0.97M	-1.60M	-0.72M	-0.47M	-0.44M	-0.76M	-0.69M	-0.70M	-0.46M	-0.86M	-0.79M	-1.20M
Additional items
EPS (Basic) (Quarter)	-0.04	-0.09	0.00	-0.04	-0.05	-0.04	-0.03	-0.04	-0.02	-0.03	-0.01	-0.02	-0.01	-0.01	-0.01	-0.02	-0.01	-0.01	-0.01	-0.01
EPS (Weighted Average and Diluted) (Quarter)	-0.04	-0.09	0.00	-0.04	-0.05	-0.04	-0.03	-0.04	-0.02	-0.03	-0.01	-0.01	-0.01	-0.01	-0.01	-0.02	-0.01	-0.01	-0.01	-0.01
Shares Outstanding (Weighted Average) (Quarter)	13.17M	13.23M	13.42M	13.38M	20.68M	26.34M	27.34M	35.59M	0.05M	50.97M	0.83M	28.58M	54.75M	55.99M	55.93M	57.34M	68.29M	73.59M	76.35M	78.41M
Shares Outstanding (Diluted Average) (Quarter)	13.17M	13.28M	13.42M	13.38M	20.68M	26.34M	34.83M	32.51M	0.05M	50.14M	50.59M	51.13M	54.75M	55.99M	55.93M	57.34M	68.29M	73.59M	81.69M	78.41M
EBITDA (Quarter)	-0.82M	-0.56M	-0.49M	-0.43M	-0.44M	-0.72M	-1.22M	-0.95M	-0.84M	-1.50M	-0.62M	-0.48M	-0.36M	-0.66M	-0.56M	-0.53M	-0.41M	-0.76M	-0.48M	-0.71M

Research Tools

Guided Therapeutics Income Statement (2010-2025) | GTHP

Create an account

Sign In

Reset Password